Second Affiliated Hospital Of Nanchang University
Clinical trials sponsored by Second Affiliated Hospital Of Nanchang University, explained in plain language.
-
New combo therapy aims to make inoperable lung cancer operable
Disease control Recruiting nowThis study tests whether a special radiation method (SFRT) given alongside immunotherapy (tislelizumab) and standard chemotherapy can shrink stage III lung tumors that cannot be surgically removed. The goal is to see if this combination makes more patients eligible for surgery. T…
Phase: PHASE2, PHASE3 • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Double-Drug attack targets tough lung cancer
Disease control Recruiting nowThis trial investigates whether combining two targeted drugs, vebreltinib and furmonertinib, can control advanced non-small cell lung cancer in people whose tumors have both an EGFR mutation and high PD-L1 expression. The study enrolls about 45 adults who have not received prior …
Phase: PHASE1, PHASE2 • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New combo treatment aims to boost recovery after severe brain bleed
Disease control Recruiting nowThis study tests whether starting lumbar drainage and injecting the clot-busting drug urokinase early after a severe brain bleed improves patients' recovery. About 424 adults with a first-time severe aneurysmal subarachnoid hemorrhage will be randomly assigned to get either the a…
Phase: PHASE4 • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a common antidepressant supercharge lung cancer treatment?
Disease control Recruiting nowThis phase 2 trial is testing whether adding the antidepressant olanzapine to standard immunotherapy (nivolumab) helps people with advanced EGFR-negative non-small cell lung cancer live longer. About 156 participants will receive either the combination or immunotherapy alone for …
Phase: PHASE2 • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New combo therapy takes on bulky tumors
Disease control Recruiting nowThis phase 2 trial is testing a new approach for people with large, relapsed solid tumors that have not responded to standard treatments. It combines a special type of radiation (spatially fractionated radiation therapy) with two immunotherapy drugs (iparomlimab and tuvonralimab)…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New combo therapy targets hard-to-treat brain metastasis in lung cancer patients
Disease control Recruiting nowThis study tests a higher dose of a targeted therapy (EGFR-TKI) combined with two other drugs for people with advanced lung cancer that has spread to the lining of the brain and worsened on standard treatment. About 30 participants will receive the triple combination to see if it…
Phase: NA • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Diabetes drug semaglutide takes on dieting in fatty liver showdown
Disease control Recruiting nowThis study compares weekly semaglutide injections to a calorie-restricted diet in 100 adults with type 2 diabetes and fatty liver disease. Over 12 weeks, researchers will measure changes in blood sugar, weight, inflammation, and liver fat. The goal is to see which approach works …
Phase: PHASE4 • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Could 'Good' eye bacteria ease dry eye? new trial launches
Disease control Recruiting nowThis study tests whether transplanting healthy bacteria from the eye's surface can help people with moderate to severe dry eye. Forty participants will either receive the bacteria transplant or a fake procedure. Researchers will measure changes in eye discomfort and surface damag…
Phase: PHASE1, PHASE2 • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Probiotic MR-61: a gut feeling against myopia?
Disease control Recruiting nowThis study tests whether a probiotic called MR-61 can help slow the worsening of nearsightedness (myopia) in children and teens aged 3 to 18. Participants will take either the probiotic or a placebo daily for a period, and researchers will measure changes in their vision and eye …
Phase: PHASE2 • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New procedure could replace pills for Hormone-Driven high blood pressure
Disease control Recruiting nowThis study tests whether a procedure called superselective adrenal artery embolization can improve blood vessel function in people with primary aldosteronism, a condition where the adrenal glands make too much of the hormone aldosterone, causing high blood pressure. The procedure…
Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
AI eye doctor: algorithm aims to predict SMILE surgery risks
Diagnosis Recruiting nowThis study tests an artificial intelligence (AI) algorithm that analyzes videos from SMILE eye surgery to predict complications like cloudy bubbles or suction loss during the procedure, as well as outcomes like vision correction and corneal thickness afterward. Researchers will e…
Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
AI eye doctor: smart software aims to perfect lens implants for nearsightedness
Diagnosis Recruiting nowThis study tests whether a computer program (a deep neural network) can accurately predict the best lens size and position for people having surgery to correct nearsightedness. About 326 adults aged 18-45 will have their eyes scanned before surgery, and the AI's predictions will …
Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
New nursing approach aims to boost recovery after varicose vein surgery
Symptom relief Recruiting nowThis study tests a specially designed nursing program for people recovering from varicose vein surgery. The program focuses on teaching patients how to manage their own recovery, including daily activities and medical care. Researchers will measure whether this approach improves …
Phase: NA • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New wire may cut X-Ray risk during heart ablation
Symptom relief Recruiting nowThis study compares a new guidewire (AccuSafe) to the standard needle used to cross the heart wall during catheter ablation for atrial fibrillation. The goal is to see if the guidewire is safer and more effective, especially when done without X-ray guidance. 80 patients will be r…
Phase: NA • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
New combo injection aims to ease pain after rotator cuff surgery
Symptom relief Recruiting nowThis study tests whether adding a long-acting painkiller (liposomal bupivacaine) to a standard steroid injection during shoulder surgery can improve recovery for people with rotator cuff tears and shoulder stiffness. About 70 adults will be randomly assigned to receive either the…
Phase: NA • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Could a simple score predict dementia in depressed seniors?
Knowledge-focused Recruiting nowThis study aims to create a risk score that uses information from electronic medical records to predict the chance of developing dementia within 5, 9, or 13 years in older adults with depression. Researchers will analyze data from 44 participants aged 50 and older who have a depr…
Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
2 million people join study to see if 'Aging Clock' predicts disease and death
Knowledge-focused Recruiting nowThis study looks at whether a measure called Phenotypic Age Acceleration (PhenoAgeAccel), calculated from routine blood tests, can predict who will develop major chronic diseases like diabetes, dementia, cancer, or lung disease, and how long they might live. Researchers will foll…
Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
AI could revolutionize bleeding stroke diagnosis and prognosis
Knowledge-focused Recruiting nowThis study aims to create an artificial intelligence (AI) model to help doctors diagnose and predict recovery for people with a bleeding stroke (spontaneous intracerebral hemorrhage). The researchers will use brain scans and other data from 7,100 patients to train the AI. The goa…
Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
5,000 patients enrolled to build brain bleed prediction tool
Knowledge-focused Recruiting nowThis study is tracking 5,000 people who had a brain bleed from a ruptured aneurysm. Researchers are collecting medical data to find factors that predict complications like delayed brain injury or long-term disability. The goal is to create a computer model that helps doctors fore…
Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
Tiny lens left behind may affect vision after laser eye surgery
Knowledge-focused Recruiting nowThis study looks at why some people develop higher-order vision distortions after SMILE laser eye surgery when a tiny piece of the removed lens is left in the eye. Researchers will measure changes in the eye's surface shape before and after surgery in 33 people. The goal is to un…
Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC